Many seeds and legumes that are not required to carry mandatory allergen warnings often cause severe allergic reactions, ...

SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to ...

Please provide your email address to receive an email when new articles are posted on . Successful treatment of anaphylaxis symptoms with a single dose of neffy 2 mg was found in 89.2% of patients in ...

Based on real-world data, 92.3% of patients achieved rapid symptom resolution after receiving a single dose of epinephrine nasal spray for systemic reactions. Intranasal epinephrine was found to be ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Please provide your email address to receive an email when new articles are posted on . The consensus aims to rectify discrepancies between prior statements. The report was drafted to be understood by ...

AllergyAware e-learning course significantly improved school personnel's anaphylaxis knowledge and confidence in using epinephrine auto-injectors. Food allergies increase anaphylaxis risk, impacting ...

Angioedema and anaphylaxis are two different conditions, but they share many of the same triggers and symptoms. Angioedema is swelling in the tissues underneath the skin. It’s marked by sudden changes ...

Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection Figure 1: Treatment success rate with a single dose of neffy administered by a ...

Results suggest real-world effectiveness of neffy is consistent with that historically reported for epinephrine injection This data from the neffy experience program is consistent with clinical trials ...